CrkL anticorps (C-Term)
Aperçu rapide pour CrkL anticorps (C-Term) (ABIN121674)
Antigène
Voir toutes CrkL (CRKL) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Purification
- Affinity chromatography
-
Immunogène
- Synthetic peptide sequence KIFDPQNPDENE derived from C-terminus of CRKL
-
-
-
-
Indications d'application
-
Western Blot: 1/200 - 1/500, this antibody detects a band of approximately 33 kDa in mouse kidney cell lysates, overnight incubation with primary antibody is recommended.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- TRIS buffered saline pH 7.3 containing 0.02 % Sodium Azide and 0.5 % Bovine Serum Albumin
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
-
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer. Avoid repeated freezing and thawing.
Shelf Life: one year from despatch. -
Date de péremption
- 12 months
-
-
- CrkL (CRKL) (V-Crk Sarcoma Virus CT10 Oncogene Homolog (Avian)-Like (CRKL))
-
Autre désignation
- CRKL
-
Sujet
- CRKL is a 33 kDa adaptor protein which has been shown to activate the RAS and JUN kinase signalling pathways and transforms fibroblasts in a RAS-dependant manner. CRKL is a substitute of BCR-ABL tyrosine kinase.Synonyms: Crk-like protein, v-crk avian sarcoma virus CT10 oncogene homolog-like
-
Pathways
- Interferon-gamma Pathway, Neurotrophin Signaling Pathway, Signaling of Hepatocyte Growth Factor Receptor
Antigène
-